Boehringer Ingelheim
Whoa! How did you get here? This company profile is not meant to be publicly available. Research on this company is incomplete, and the overall rating has been disabled, but while you are here feel free to have a look at the info we do have.
OVERALL |
|
Owned |
GER |
Rating |
N/A |
Pharmaceuticals
Worlds largest privately owned pharmaceuticals company.
C H Boehringer Sohn AG & Co KG | GER | website |
Company Assessment
PRAISE | CRITICISM | INFORMATION | ||
C H Boehringer Sohn AG & Co KG | ||||
The Green Supply Chain Corporate Information Transparency Index (CITI) evaluates consumer-facing companies that have a sizeable supply chain in China. The evaluation uses government supervision data and public information to assess the environmental management of their supply chains in China. This company received a score of 7.3/100 (retrieved 24 Nov 2023).
Source: IPE (2023)
This company was required to pay a fine of US$931,000 after a US District judge ruled it failed to preserve files crucial to the company's upcoming litigation against its blood thinner Pradaxa. The judge, presiding over more than 1700 consolidated cases, made the fine because executives acted 'in bad faith' by allegedly allowing 500,000 plus documents to disappear. Pradaxa has been linked to more than 500 deaths and thousands of complications since being marketed in 2010.
Source: Drug Watch (2013) |
In 2013 the Therapeutic Goods Administration's Complaints Resolution Panel upheld a complaint about an ad by this company on the grounds that it breached advertising codes. The ad was subsequently withdrawn.
Source: TGA Complaints Register (2013)
According to the democracyforsale.net website, this company donated $174,169 to Australia's major political parties between 2012 and 2018, as disclosed to the Australian Electoral Commision (AEC).
Source: Democracy For Sale (2018)
This company was named in Seramount's 100 Best Companies 2022 for being a mum-friendly employer. Listed companies provide inclusive benefits for families, including paid gender-neutral parental leave, phase-back programs, bereavement leave after miscarriage, reimbursement for fertility expenses, and increased mental health benefits for employees.
Source: Seramount (2022)
This company is a member of the AMR Industry Alliance, a coalition of biotech, diagnostics, generics and research-based pharmaceutical companies set up to provide sustainable solutions to curb antimicrobial resistance (AMR). AMR is an increasingly significant threat to global public health which puts at risk the effective prevention and treatment of a wide range of infections.
Source: AMR Industry Alliance (2021)
This company received the thirteenth highest score in the Access to Medicine Index 2022, a ranking of the world's 20 largest pharmaceutical companies on their efforts to increase access to medicine in developing countries. The ranking is based on their scores in each Technical Area, with Product Delivery weighted most highly, followed by R&D and Governance of Access.
Source: Access to Medicine Foundation (2022) |
Company Details
Type | Private company |
Contact Details
Address | Germany |
Website | boehringer-ingelheim.com |